Correspondence 0001104659-23-089326 from NextCure, Inc. (NXTC)

NextCure, Inc.
Date: Aug. 9, 2023 · CIK: 0001661059 · Accession: 0001104659-23-089326

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-273723

Date

Aug. 9, 2023

Author

/s/ Michael Richman

Form

CORRESP

Company

NextCure, Inc.

Letter

Re: Acceleration Request for NextCure, Inc.

August 9, 2023

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention: Dillon Hagius

Registration Statement on Form S-3 (File No. 333-273723)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, NextCure, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-3, Registration Number 333-273723 (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 P.M., Eastern Time or as soon thereafter as practicable, on August 11, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.

[Signature Page Immediately Follows]

We would appreciate it if, as soon as the Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at (212) 839-5651.

Very truly yours,
/s/ Michael Richman

Show Raw Text

CORRESP
1
filename1.htm

August
9, 2023

Via
EDGAR

U.S. Securities
and Exchange Commission

Division
of Corporation Finance

100 F Street,
N.E.

Washington,
D.C. 20549-3720

Attention: Dillon
                                            Hagius

    Re:
    Acceleration
    Request for NextCure, Inc.

    Registration
    Statement on Form S-3 (File No. 333-273723)

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, NextCure, Inc. (the “Company”), hereby requests that
the effective date of the Company’s Registration Statement on Form S-3, Registration Number 333-273723 (the “Registration
Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 P.M., Eastern
Time or as soon thereafter as practicable, on August 11, 2023, or at such later time as the Company
or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange
Commission.

[Signature
Page Immediately Follows]

We
would appreciate it if, as soon as the Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at
(212) 839-5651.

    Very truly yours,

    /s/ Michael Richman

    Michael Richman

    President and Chief Executive Officer

    cc:
    Steven P. Cobourn, NextCure, Inc.

    Asher M. Rubin, Sidley Austin LLP

    Istvan A. Hajdu, Sidley Austin LLP

    Kostian Ciko, Sidley Austin LLP

SecProbe.io